Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs

被引:71
作者
Barinka, Cyril [1 ]
Hlouchova, Klara [2 ,3 ]
Rovenska, Miroslava [2 ,3 ]
Majer, Pavel [4 ]
Dauter, Miroslawa [5 ]
Hin, Niyada [4 ]
Ko, Yao-Sen [4 ]
Tsukamoto, Takashi [4 ]
Slusher, Barbara S. [4 ]
Konvalinka, Jan [2 ,3 ]
Lubkowski, Jacek [1 ]
机构
[1] NCI, Ctr Canc Res, Frederick, MD 21701 USA
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Gilead Sci & IOCB Res Ctr, Prague 6, Czech Republic
[3] Charles Univ Prague, Fac Nat Sci, Dept Biochem, Prague 2, Czech Republic
[4] MGI Pharma Inc, Baltimore, MD USA
[5] SAIC Frederick Inc, Basic Res Program, Argonne Natl Lab, Argonne, IL USA
关键词
prostate-specific membrane antigen; metallopeptidase; folate hydrolase; NAALADase; phosphapeptide;
D O I
10.1016/j.jmb.2007.12.066
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human glutamate carboxypeptidase II (GCPII) is involved in neuronal signal transduction. and intestinal folate absorption by means of the hydrolysis of its two natural substrates, N-acetyl-aspartyl-glutamate and folyl-poly-gamma-glutamates, respectively. During the past years, tremendous efforts have been made toward the structural analysis of GCPII. Crystal structures of GCPII in complex with various ligands have provided insight into the binding of these ligands, particularly to the S1' site of the enzyme. In this article, we have extended structural characterization of GCPII to its S1 site by using dipeptide-based inhibitors that interact with both S1 and S1' sites of the enzyme. To this end, we have determined crystal structures of human GCPII in complex with phosphapeptide analogs of folyl-gamma-glutamate, aspartyl-glutamate, and gamma-glutamyl-glutamate, refined at 1.50, 1.60, and 1.67 angstrom resolution, respectively. The S1 pocket of GCPII could be accurately defined and analyzed for the first time, and the data indicate the importance of Asn519, Arg463, Arg534, and Arg536 for recognition of the penultimate (i.e., P1) substrate residues. Direct interactions between the positively charged guanidinium groups of Arg534 and Arg536 and a P1 moiety of a substrate/inhibitor provide mechanistic explanation of GCPII preference for acidic dipeptides. Additionally, observed conformational flexibility of the Arg463 and Arg536 side chains likely regulates GCPII affinity toward different inhibitors and modulates GCPII substrate specificity. The biochemical experiments assessing the hydrolysis of several GCPII substrate derivatives modified at the P1 position, also included in this report, further complement and extend conclusions derived from the structural analysis. The data described here form an a solid foundation for the structurally aided design of novel low-molecular-weight GCPII inhibitors and imaging agents. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1438 / 1450
页数:13
相关论文
共 43 条
  • [1] Substrate specificity of prostate-specific membrane antigen
    Anderson, Marc O.
    Wu, Lisa Y.
    Santiago, Nicholas M.
    Moser, Jamie M.
    Rowley, Jennifer A.
    Bolstad, Erin S. D.
    Berkman, Clifford E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (21) : 6678 - 6686
  • [2] Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II
    Barinka, C
    Rinnová, M
    Sácha, P
    Rojas, C
    Majer, P
    Slusher, BS
    Konvalinka, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (03) : 477 - 487
  • [3] Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II
    Barinka, Cyril
    Rovenska, Miroslava
    Mlcochova, Petra
    Hlouchova, Klara
    Plechanovova, Anna
    Majer, Pavel
    Tsukamoto, Takashi
    Slusher, Barbara S.
    Konvalinka, Jan
    Lubkowski, Jacek
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (14) : 3267 - 3273
  • [4] A high-resolution structure of ligand-free human glutamate carboxypeptidase II
    Barinka, Cyril
    Starkova, Jana
    Konvalinka, Jan
    Lubkowski, Jacek
    [J]. ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2007, 63 : 150 - 153
  • [5] Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO
  • [6] 2-S
  • [7] Further additions to MolScript version 1.4, including reading and contouring of electron-density maps
    Esnouf, RM
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 : 938 - 940
  • [8] Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
    Foss, CA
    Mease, RC
    Fan, H
    Wang, YC
    Ravert, HT
    Dannals, RF
    Olszewski, RT
    Heston, WD
    Kozikowski, AP
    Pomper, MG
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4022 - 4028
  • [9] Folylpoly-γ-glutamate carboxypeptidase from pig jejunum -: Molecular characterization and relation to glutamate carboxypeptidase II
    Halsted, CH
    Ling, EH
    Luthi-Carter, R
    Villanueva, JA
    Gardner, JM
    Coyle, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 20417 - 20424
  • [10] Biochemical characterization of human glutamate carboxypeptidase III
    Hlouchova, Klara
    Barinka, Cyril
    Klusak, Vojtech
    Sacha, Pavel
    Mlcochova, Petra
    Majer, Pavel
    Rulisek, Lubomir
    Konvalinka, Jan
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 682 - 696